Related Experiment Videos
MUC-1 mucin protein expression in B-cell lymphomas
Julie Teruya-Feldstein1, Gerard B Donnelly, Andre Goy
1Department of Pathology, Cell Biology and Immunology Programs, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. feldstej@mskcc.org
Summary
MUC-1 mucin is highly expressed in most B-cell lymphomas, regardless of MUC1 gene alterations. This expression is linked to a prior lymphoma history, suggesting potential clinical relevance in B-cell malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Immunohistochemistry
Background:
- MUC1 gene rearrangements/amplifications occur in 15% of B-cell lymphomas.
- Rearrangement of MUC1 was previously linked to MUC-1 mucin overexpression in diffuse large B-cell lymphoma (DLBCL).
Purpose of the Study:
- To assess the incidence of MUC-1 mucin expression in various B-cell lymphomas.
- To determine the clinical significance of MUC-1 mucin expression in these lymphomas.
Main Methods:
- Immunohistochemistry (IHC) was used to evaluate MUC-1 mucin expression in 113 B-cell lymphoma cases.
- Southern blot and karyotypic analysis were performed to assess MUC1 genomic status and 1q21 abnormalities.
Main Results:
- MUC-1 mucin expression was detected in 92.9% of cases.
- Moderate to high MUC-1 mucin levels were observed in 50.4% of DLBCL, follicular lymphoma (FL), and other B-cell lymphomas.
- No significant correlation was found between MUC-1 mucin expression and MUC1 genomic status or 1q21 abnormalities.
- MUC-1 mucin expression showed a significant correlation with a previous history of lymphoma (p=0.003).
Conclusions:
- MUC-1 mucin is broadly expressed across B-cell lymphoma subtypes.
- MUC-1 mucin expression is not directly linked to MUC1 gene amplification or rearrangement in this cohort.
- Previous lymphoma history is associated with MUC-1 mucin expression, warranting further investigation into its clinical significance.